Rare Diseases

Where we meet every challenge with confidence.

With more than 20 years’ experience,

Aixial understands rare disease trials are unique.

Our rare disease experienced teams’ will provide proactive risk identification and mitigation specific to your target indication.

Aixial team, your trusted partner

Our global team consists of highly qualified medical, scientific, regulatory, and operational professionals with extensive experience in global drug development. They are backed by a network of Key Opinion Leaders (KOLs) and industry contacts. Each team member is dedicated to making a meaningful impact on the design and effective operational delivery of your rare disease trial, ensuring success in every aspect, including:

  • Expert consultancy on business, regulatory issues, medical and scientific objectives. We can also offer a detailed review of a trial’s operational aspects.
  • In-depth and up-to-date knowledge of the global regulatory environment and legislation. That includes clinical trial supplies issues and the most appropriate solutions.
  • A global network of investigators who have a track record of high enrolment enhanced by internal and external database searches.

Ask us about


  • Regulatory pathway selection
  • Patient enrolment and logitics
  • Trial design
  • Country and site selection
  • Medicinal product logistics
  • Data collection and delivery

Our exceptional experience of designing and delivering studies for many rare diseases includes these indications:

Acromegaly

Alpha-1 Antitrypsin Deficiency (AATD)

Alpha – Mannosidosis

APDS

Autoimmune indications

Beta-thalassemia

Cluster Headache

Cushing’s Disease

Cystic Fibrosis

Eisenmenger Sydrome

Fabry Disease

Fragile X

Hereditary Angioedema

Hurler’s Disease

Inclusion Body Miositis

Inherited Metabolic Disorders

Lipoprotein Lipase Deficiency

Malignant rare diseases

Multiple Sclerosis

Myasthenia Gravis

Myositis

Netherton Syndrome

Nevoid Basal Cell Carcinoma Syndrome

NOMID/CINCA Syndrome

Noonan Syndrome

Paroxysmal Nocturnal Hemaglobinuria

PASLI Disease

Pediatric Hypertension

Pemphigus Vulgaris

Phosphomannomuttase

Pigmented Villonodular Synovitis

Primary Biliary Cholangitis

Primary Biliary Cirrhosis

Primary Hyperaldosteronism

Pulmonary Fibrosis

Raynaud’s Disease

Rheumatoid Arthritis

Sarcoidosis

Sickle Cell Disease

Sjogren’s Syndrome

Sjogren’s Syndrome

Spinal Muscular Atrophy (SMA)

Systemic Sclerosis

Tuberculosis

Type 1 Spinal Muscular Atrophy

Uveitis

Visceral Leishmaniasis

Wilson’s Disease

X-Linked Severe Combined Immunodeficency

How can support your next project?

Whether you’re looking for a protocol review or a proposal,

simply reach out to us by filling our request for proposal.

Insights